Annual Current Ratio
1.13
-2.46-68.52%
December 31, 2022
Summary
- As of February 10, 2025, NBRV annual current ratio is 1.13, with the most recent change of -2.46 (-68.52%) on December 31, 2022.
- During the last 3 years, NBRV annual current ratio has fallen by -4.35 (-79.38%).
Performance
NBRV Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Ratio
0.85
-0.28-24.78%
March 31, 2023
Summary
- As of February 10, 2025, NBRV quarterly current ratio is 0.85, with the most recent change of -0.28 (-24.78%) on March 31, 2023.
- Over the past year, NBRV quarterly current ratio has dropped by -3.16 (-78.80%).
Performance
NBRV Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Ratio Formula
Current Ratio = Current Assets
Current Liabilities
Current Assets
Current Liabilities
Current Liabilities
NBRV Current Ratio Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -68.5% | -78.8% |
| 3 y3 years | -79.4% | -73.3% |
| 5 y5 years | -84.0% | -90.2% |
NBRV Current Ratio Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -68.5% | at low | -78.8% | at low |
| 5 y | 5-year | -79.4% | at low | -85.0% | at low |
| alltime | all time | -91.3% | -90.3% | -93.5% | -87.1% |
Nabriva Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | 0.85(-24.8%) |
| Dec 2022 | 1.13(-68.5%) | 1.13(-48.6%) |
| Sep 2022 | - | 2.20(-21.7%) |
| Jun 2022 | - | 2.81(-29.9%) |
| Mar 2022 | - | 4.01(+11.7%) |
| Dec 2021 | 3.59(+16.2%) | 3.59(-19.9%) |
| Sep 2021 | - | 4.48(-9.1%) |
| Jun 2021 | - | 4.93(+14.9%) |
| Mar 2021 | - | 4.29(+38.8%) |
| Dec 2020 | 3.09(-43.6%) | 3.09(-37.6%) |
| Sep 2020 | - | 4.95(-12.9%) |
| Jun 2020 | - | 5.68(+78.1%) |
| Mar 2020 | - | 3.19(-41.8%) |
| Dec 2019 | 5.48(-10.3%) | 5.48(-5.7%) |
| Sep 2019 | - | 5.81(+2.5%) |
| Jun 2019 | - | 5.67(+2.2%) |
| Mar 2019 | - | 5.55(-9.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | 6.11(-13.7%) | 6.11(-16.9%) |
| Sep 2018 | - | 7.35(-2.3%) |
| Jun 2018 | - | 7.52(-13.1%) |
| Mar 2018 | - | 8.65(+22.2%) |
| Dec 2017 | 7.08(+24.0%) | 7.08(-1.9%) |
| Sep 2017 | - | 7.22(+91.5%) |
| Jun 2017 | - | 3.77(-21.8%) |
| Mar 2017 | - | 4.82(-15.6%) |
| Dec 2016 | 5.71(-56.2%) | 5.71(-2.7%) |
| Sep 2016 | - | 5.87(-25.4%) |
| Jun 2016 | - | 7.87(+2.1%) |
| Mar 2016 | - | 7.71(-40.8%) |
| Dec 2015 | 13.03(>+9900.0%) | 13.03(+14.9%) |
| Sep 2015 | - | 11.34(+273.0%) |
| Jun 2015 | - | 3.04(+2663.6%) |
| Mar 2015 | - | 0.11(0.0%) |
| Dec 2014 | 0.11(-64.5%) | 0.11 |
| Dec 2013 | 0.31 | - |
FAQ
- What is Nabriva Therapeutics annual current ratio?
- What is the all time high annual current ratio for Nabriva Therapeutics?
- What is Nabriva Therapeutics annual current ratio year-on-year change?
- What is Nabriva Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Nabriva Therapeutics?
- What is Nabriva Therapeutics quarterly current ratio year-on-year change?
What is Nabriva Therapeutics annual current ratio?
The current annual current ratio of NBRV is 1.13
What is the all time high annual current ratio for Nabriva Therapeutics?
Nabriva Therapeutics all-time high annual current ratio is 13.03
What is Nabriva Therapeutics annual current ratio year-on-year change?
Over the past year, NBRV annual current ratio has changed by -2.46 (-68.52%)
What is Nabriva Therapeutics quarterly current ratio?
The current quarterly current ratio of NBRV is 0.85
What is the all time high quarterly current ratio for Nabriva Therapeutics?
Nabriva Therapeutics all-time high quarterly current ratio is 13.03
What is Nabriva Therapeutics quarterly current ratio year-on-year change?
Over the past year, NBRV quarterly current ratio has changed by -3.16 (-78.80%)